21-29092509-A-G

Variant summary

Our verdict is Likely benign. The variant received -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate

The NM_001286617.2(MAP3K7CL):​c.-241A>G variant causes a 5 prime UTR premature start codon gain change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000342 in 1,461,890 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).

Frequency

Genomes: not found (cov: 33)
Exomes 𝑓: 0.0000034 ( 0 hom. )

Consequence

MAP3K7CL
NM_001286617.2 5_prime_UTR_premature_start_codon_gain

Scores

18

Clinical Significance

Likely benign criteria provided, single submitter B:1

Conservation

PhyloP100: -0.0880

Publications

0 publications found
Variant links:
Genes affected
MAP3K7CL (HGNC:16457): (MAP3K7 C-terminal like) Located in cytosol and nucleus. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -4 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.026842773).
BP6
Variant 21-29092509-A-G is Benign according to our data. Variant chr21-29092509-A-G is described in ClinVar as [Likely_benign]. Clinvar id is 3123025.Status of the report is criteria_provided_single_submitter, 1 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MAP3K7CLNM_001286617.2 linkc.-241A>G 5_prime_UTR_premature_start_codon_gain_variant Exon 5 of 10 NP_001273546.1 P57077-4B0EVZ8B0EVZ6
MAP3K7CLNM_001286618.2 linkc.-112A>G 5_prime_UTR_premature_start_codon_gain_variant Exon 5 of 9 NP_001273547.1 P57077-4B0EVZ8B0EVZ6
MAP3K7CLNM_001286619.2 linkc.-385A>G 5_prime_UTR_premature_start_codon_gain_variant Exon 1 of 7 NP_001273548.1 P57077-4B4DFW0B0EVZ8

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MAP3K7CLENST00000341618.8 linkc.298A>G p.Thr100Ala missense_variant Exon 5 of 8 1 ENSP00000343212.4 P57077-1
MAP3K7CLENST00000399947.6 linkc.298A>G p.Thr100Ala missense_variant Exon 6 of 9 1 ENSP00000382828.2 P57077-1
MAP3K7CLENST00000496779.5 linkn.746A>G non_coding_transcript_exon_variant Exon 6 of 7 1

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD2 exomes
AF:
0.00000398
AC:
1
AN:
251494
AF XY:
0.00000736
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00000879
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000342
AC:
5
AN:
1461890
Hom.:
0
Cov.:
30
AF XY:
0.00000550
AC XY:
4
AN XY:
727246
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33480
American (AMR)
AF:
0.00
AC:
0
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86258
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53420
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5768
European-Non Finnish (NFE)
AF:
0.00000450
AC:
5
AN:
1112008
Other (OTH)
AF:
0.00
AC:
0
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
33
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.00000378
ExAC
AF:
0.00000824
AC:
1
EpiCase
AF:
0.00
EpiControl
AF:
0.0000593

ClinVar

Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Benign:1
Jan 24, 2024
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
-0.29
T
BayesDel_noAF
Benign
-0.65
CADD
Benign
8.5
DANN
Benign
0.78
DEOGEN2
Benign
0.0032
T;T;T
Eigen
Benign
-1.2
Eigen_PC
Benign
-1.2
FATHMM_MKL
Benign
0.033
N
LIST_S2
Benign
0.26
.;.;T
M_CAP
Benign
0.0022
T
MetaRNN
Benign
0.027
T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
0.0
N;N;N
PhyloP100
-0.088
PrimateAI
Benign
0.24
T
PROVEAN
Benign
-0.21
N;N;N
REVEL
Benign
0.031
Sift
Benign
0.17
T;T;T
Sift4G
Benign
0.32
T;T;T
Polyphen
0.0
B;B;B
Vest4
0.033
MutPred
0.25
Gain of catalytic residue at T100 (P = 0.012);Gain of catalytic residue at T100 (P = 0.012);Gain of catalytic residue at T100 (P = 0.012);
MVP
0.061
MPC
0.27
ClinPred
0.072
T
GERP RS
-3.5
PromoterAI
0.10
Neutral
Varity_R
0.043
gMVP
0.069
Mutation Taster
=98/2
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs776413595; hg19: chr21-30464830; API